Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Celldex Therapeutics, Inc](/topic/$cldx)

### Sentiment: %
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$cldx/time-series/sentiment.tsv)  
**Current Value**: %  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XX% +18%  
**6 Months**: XX% -XX%  
**1 Year**: XX% +8%  
**1-Year High**: XXX% on 2024-10-20  
**1-Year Low**: XX% on 2025-02-08  

**Most Supportive Themes**
- **Positive Trial Data and Biotech Momentum:** (35%) Posts highlight positive trial data and the overall positive momentum within the biotech sector, suggesting optimism for Celldex Therapeutics.
- **Analyst Ratings and Price Targets:** (25%) Mentions of analyst ratings and price targets, with some analysts reiterating 'Buy' ratings and setting higher price targets for CLDX.
- **Product Advancements and Partnerships:** (15%) News about advancements in treatments like Dupixent and partnerships, indicating potential growth and market expansion for Celldex.
  
**Most Critical Themes**
- **Price Volatility and Market Cap Concerns:** (10%)  Some posts mention the stock's volatility and the current market cap, with one post suggesting the stock is being 'pumped' and could be a meme stock.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %   | Negative | %  |
| ------- | -------- | -  | ------- | -   | -------- | -  |
| X       | X        | X% | XXX     | XX% | XX       | X% |
|         |          |    |         |     |          |    |
| Total   | X        | X% | XXX     | XX% | XX       | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Celldex Therapeutics, Inc

Sentiment: %

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: %
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% +18%
6 Months: XX% -XX%
1 Year: XX% +8%
1-Year High: XXX% on 2024-10-20
1-Year Low: XX% on 2025-02-08

Most Supportive Themes

  • Positive Trial Data and Biotech Momentum: (35%) Posts highlight positive trial data and the overall positive momentum within the biotech sector, suggesting optimism for Celldex Therapeutics.
  • Analyst Ratings and Price Targets: (25%) Mentions of analyst ratings and price targets, with some analysts reiterating 'Buy' ratings and setting higher price targets for CLDX.
  • Product Advancements and Partnerships: (15%) News about advancements in treatments like Dupixent and partnerships, indicating potential growth and market expansion for Celldex.

Most Critical Themes

  • Price Volatility and Market Cap Concerns: (10%) Some posts mention the stock's volatility and the current market cap, with one post suggesting the stock is being 'pumped' and could be a meme stock.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X X X% XXX XX% XX X%
Total X X% XXX XX% XX X%
Celldex Therapeutics, Inc (CLDX) Sentiment
/topic/$cldx/sentiment